Axolabs GmbH

• Short facts

• • Research & Development
• Year founded 2011
• 200 Employees (site)
• Turnover: 5m - <10m EUR

Products/services: Axolabs GmbH, Kulmbach, is the world’s leading custom research organization in the field of preclinical and clinical development of DNA-/RNA-based therapeutics and nucleic acid medicines. We are committed to providing high-end solutions and consultancy services for the development of innovative drugs. Our expert team has 20+ years of experience in the development of oligonucleotide therapeutics and has access to excellent infrastructure. We are well known, from big-pharma and biotech to academia and venture capital, for our profound knowledge, high quality standards and excellent research. Our broad range of services for therapeutic oligonucleotides and mRNAs covers, in particular, bioinformatics, chemical synthesis of oligonucleotides, oligonucleotide conjugates and formulations, analytics, bioanalytics and in vitro testing. Axolabs GmbH, Kulmbach, is the world’s leading custom research organization in the field of preclinical and clinical development of DNA-/RNA-based therapeutics and nucleic acid medicines. We are committed to providing high-end solutions and consultancy services for the development of innovative drugs. Our expert team has 20+ years of experience in the development of oligonucleotide therapeutics and has access to excellent infrastructure. We are well known, from big-pharma and biotech to academia and venture capital, for our profound knowledge, high quality standards and excellent research. Our broad range of services for therapeutic… read more